Auna (NYSE:AUNA) Downgraded by Zacks Research to “Strong Sell”

Zacks Research downgraded shares of Auna (NYSE:AUNA) from a hold rating to a strong sell rating in a research note published on Tuesday morning,Zacks.com reports.

Other analysts have also issued reports about the company. Jefferies Financial Group began coverage on Auna in a research report on Friday, January 16th. They set a “buy” rating and a $9.00 target price on the stock. JPMorgan Chase & Co. reiterated a “neutral” rating and set a $6.00 target price (down from $13.50) on shares of Auna in a research note on Tuesday, November 18th. Wall Street Zen upgraded shares of Auna from a “buy” rating to a “strong-buy” rating in a research note on Saturday, January 3rd. HSBC upgraded shares of Auna from a “hold” rating to a “buy” rating and set a $6.90 price objective on the stock in a research note on Wednesday, January 21st. Finally, Hsbc Global Res raised shares of Auna from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, January 20th. One research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, one has given a Hold rating and two have given a Sell rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $7.30.

Auna Trading Down 3.2%

Shares of NYSE AUNA traded down $0.17 during trading on Tuesday, hitting $5.13. 93,498 shares of the company traded hands, compared to its average volume of 316,397. The company has a quick ratio of 0.82, a current ratio of 0.90 and a debt-to-equity ratio of 1.63. The firm has a market capitalization of $379.67 million, a P/E ratio of 7.23 and a beta of 2.26. The company has a 50-day moving average price of $4.82 and a 200-day moving average price of $5.71. Auna has a 1 year low of $4.47 and a 1 year high of $9.24.

Auna (NYSE:AUNA) last released its quarterly earnings data on Friday, November 21st. The company reported $0.20 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.15 by $0.05. The company had revenue of $322.08 million during the quarter, compared to the consensus estimate of $1.14 billion. Auna had a net margin of 4.40% and a return on equity of 13.52%. On average, equities analysts predict that Auna will post 0.5 EPS for the current year.

Hedge Funds Weigh In On Auna

Institutional investors and hedge funds have recently bought and sold shares of the stock. S Bank Fund Management Ltd bought a new stake in Auna during the second quarter worth approximately $126,000. HBK Sorce Advisory LLC acquired a new stake in Auna in the 2nd quarter valued at about $62,000. Fiera Capital Corp raised its holdings in shares of Auna by 2.7% in the 2nd quarter. Fiera Capital Corp now owns 1,558,358 shares of the company’s stock worth $9,662,000 after purchasing an additional 40,673 shares in the last quarter. Millennium Management LLC acquired a new stake in Auna during the third quarter valued at approximately $83,000. Finally, Citadel Advisors LLC boosted its holdings in Auna by 28.9% during the third quarter. Citadel Advisors LLC now owns 36,352 shares of the company’s stock worth $244,000 after buying an additional 8,147 shares in the last quarter.

About Auna

Auna, listed on the New York Stock Exchange under the ticker symbol AUNA, is a Peruvian integrated healthcare services company headquartered in Lima. The firm operates a diversified care network that spans hospitals, outpatient medical centers, diagnostic imaging and laboratory facilities, as well as optical and dental clinics. Auna’s organizational structure is designed to support a continuum of care model, offering both general and specialized treatments across multiple touchpoints.

The company delivers a broad range of clinical services, including emergency care, inpatient and outpatient surgery, obstetrics, cardiology, oncology, orthopedics, and other specialized disciplines.